2026/04/03
In drug development, the most valuable asset is often invisible. Before a medicine reaches patients, it exists as compound structures, experimental results, failed iterations, and proprietary know-how accumulated over years of research. Protecting that information is not just a legal requirement. It is the foundation of trust between innovators and their partners.
Read more2026/03/31
Over the past two decades, WuXi AppTec has grown alongside the global pharmaceutical and life sciences industry it serves. From a single lab to today’s multinational enterprise, the company’s development has been shaped by not only scientific collaboration and commercial partnerships, but also the attention of global investors. This has helped build a company governed by market principles and accountable to a diverse international shareholder community.
Read more2026/03/24
As a global company operating in a highly regulated pharmaceutical and life sciences industry, WuXi AppTec places compliance, transparency, and responsible business conduct at the center of its operations.
Read more2026/03/19
WuXi AppTec operates as a global enabling platform embedded within the international healthcare innovation ecosystem. Its business conduct is grounded in commercial market demand, regulatory compliance, and scientific collaboration within the global pharmaceutical and life sciences sector.
Read more2026/03/09
In the evolving global pharmaceutical and life sciences industry, WuXi AppTec stands as a platform built for science, and for the unmet needs of patients. Every day, its laboratories, offices, and manufacturing facilities are filled with scientists, engineers, and technicians whose work is guided by curiosity, rigor, and a commitment to customers and patients—not by politics or national agendas. The company’s commercial identity is woven into its governance, its workforce, and the very way it operates.
Read more